ArticleFuture healthcare journal2024
Stars, stripes and scripts: Innovations and challenges in US pharmacy.
Article in Future healthcare journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring innovations, challenges and visions for tomorrow's healthcare.Future healthcare journal · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmacy practice in the United States has evolved, transitioning from simple dispensing to complex compounding and medication management. Pharmacists play important roles across many sectors, including clinical care, pharmaceutical industry, insurance companies, and public health. Pharmacists optimize therapy, improve patient outcomes, and reduce healthcare costs. However, the profession faces challenges such as burnout, understaffing and declining insurance reimbursements, particularly in independent pharmacies. Pharmacy Benefit Managers (PBMs) have exacerbated these issues, controlling drug prices and reducing pharmacy profitability through opaque pricing and monopolistic practices. Recent legislative efforts in states like New York have aimed to curb PBM influence, however issues persist, and nationwide legislation is lacking. The future of pharmacy depends on addressing these challenges through unified lobbying and proactive reform. Despite these hurdles, scope of practice and innovation within the field continues to grow, offering hope for a revitalized pharmacy landscape.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.